Montreal, December 20, 2018 – Biron Health Group and its BiogeniQ division applaud Desjardins Insurance’s decision to include pharmacogenetic testing as an eligible expense under its accident and illness insurance coverage, at no additional cost.
In an announcement shared with its clients, Desjardins Insurance rightly states that “it is important that the investment our clients make in their health plans translates into the most appropriate treatments possible for the people insured.”
Pharmacogenetics makes it possible to treat a patient in a personalized way, based on their genetics. Pharmacogenetic testing helps increase the likelihood that a treatment will be effective, as well as reduce the risk of side effects.
BiogeniQ’s vision is to allow everyone to have a pharmacogenetic test before getting a prescription from their doctor to take medication. This is already the case in other countries, including England.
About Biron Health Group
Founded by Denis Biron in 1952, Biron now positions itself as a leader in Quebec’s health care sector. Having first built its reputation with its medical laboratory, renowned for the quality of its services, exemplary execution and quick access, Biron has diversified its service offer over the years, while always maintaining the same level of excellence. As it grew, Biron remained a family business with a human dimension, caring about its role in the community. Today, the company has 800 employees who operate more than 120 service centres throughout Quebec. Its team of dedicated experts and professionals strive every day to offer each client the simple, fast and efficient experience that has given the company its excellent reputation over the years.
For information: firstname.lastname@example.org